Ascendis Pharma Email Format

Biotechnology ResearchHovedstaden, Denmark1001-5000 Employees

Ascendis Pharma is a global biopharmaceutical company focused on applying its TransCon technology to develop therapies that address unmet medical needs. It emphasizes its core values of Patients, Science, and Passion and pursues a structured product-innovation approach. The company is headquartered in the Copenhagen region and maintains facilities across Europe and the United States.

Its development programs target rare endocrine conditions, including hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency. In March 2026, Ascendis launched Yuviwel, an achondroplasia treatment. Recent activity includes presenting data from endocrinology rare disease programs at ENDO 2026.

Sign up for free to view info

Company overview Employee directory